Establishment Labs to Release Second Quarter 2018 Financial Results on August 14, 2018
August 07, 2018 08:00 ET
|
Establishment Labs
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Establishment Labs (NASDAQ: ESTA) today announced that the Company will release its second quarter 2018 financial results on Tuesday, August 14, 2018,...
Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares
July 23, 2018 16:05 ET
|
Establishment Labs
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today...
Establishment Labs comemora oferta pública inicial na Nasdaq Stock Market (bolsa de valores Nasdaq)
July 19, 2018 11:52 ET
|
Establishment Labs
NOVA YORK, July 19, 2018 (GLOBE NEWSWIRE) -- A Establishment Labs Holdings Inc. (NASDAQ:ESTA) anunciou hoje que as ações ordinárias da empresa começaram a ser negociadas na Nasdaq Stock Market...
Establishment Labs celebra su oferta pública inicial en la bolsa de valores Nasdaq
July 19, 2018 11:52 ET
|
Establishment Labs
NUEVA YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings, Inc. (NASDAQ:ESTA) ha anunciado hoy que las acciones ordinarias de la compañía han comenzado a cotizarse en la bolsa de...
Establishment Labs Celebrates Initial Public Offering on the Nasdaq Stock Market
July 19, 2018 11:52 ET
|
Establishment Labs
NEW YORK, July 19, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA) today announced that the company’s common stock commenced trading on the Nasdaq Stock Market under the...
Establishment Labs Announces Pricing of Initial Public Offering
July 18, 2018 21:36 ET
|
Establishment Labs
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today...
Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
April 27, 2018 08:00 ET
|
Establishment Labs
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the...
Establishment Labs Appoints Jeremy Livianu as General Counsel
April 12, 2018 08:00 ET
|
Establishment Labs
NEW YORK, April 12, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on...
Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants®
March 22, 2018 13:24 ET
|
Establishment Labs
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on...
Establishment Labs designa a Dennis Condon como miembro de la junta directiva
January 09, 2018 09:48 ET
|
Establishment Labs
NUEVA YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Establishment Labs, una compañía global de dispositivos médicos enfocada en las tecnologías de estética y reconstrucción mamarias con un importante...